![Andrew Neil Charles Weir](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Andrew Neil Charles Weir
Directeur Général chez Sitryx Therapeutics Ltd.
Postes actifs de Andrew Neil Charles Weir
Sociétés | Poste | Début | Fin |
---|---|---|---|
Sitryx Therapeutics Ltd.
![]() Sitryx Therapeutics Ltd. Medical SpecialtiesHealth Technology Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | 01/04/2018 | - |
Directeur Général | 01/04/2018 | - |
Historique de carrière de Andrew Neil Charles Weir
Statistiques
Internationale
Royaume-Uni | 2 |
Opérationnelle
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Sitryx Therapeutics Ltd.
![]() Sitryx Therapeutics Ltd. Medical SpecialtiesHealth Technology Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- Andrew Neil Charles Weir
- Expérience